Pharmacokinetics of oral vinorelbine in French children with recurrent or progressive primary low-grade glioma.
Mourad HamimedFlorence GattaccecaAnne Isabelle BertozziEmmanuelle Tresch-BruneelAlicia ProbstPascal ChastagnerAnne PagnierEmilie De CarliNatacha Entz-WerléJacques GrillIsabelle AertsDidier FrappazAnne-Isabelle Bertozzi-SalamonCaroline SolasPierre LeblondPublished in: British journal of clinical pharmacology (2021)
Higher doses may be necessary for children with LGG. BSA showed a significant impact on VNR systemic exposure. We believe that our findings will serve as a basis for further studies to better characterize the concentration-response relationships of VNR among pediatric patients.